Portal de Periódicos da CAPES

Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak—Oregon, 2015–2016

2017; Oxford University Press; Volume: 216; Issue: 9 Linguagem: Inglês

10.1093/infdis/jix446

1537-6613

Lucy A. McNamara, Jennifer D. Thomas, Jessica R. MacNeil, How Yi Chang, Michael Day, Emily Fisher, Stacey W. Martin, Tasha Poissant, Susanna Schmink, Evelene Steward‐Clark, Laurel T. Jenkins, Xin Wang, Anna M. Acosta, Kristina M Angelo, Amy Blain, Pam Cassiday, Shankar Changayil, Elizabeth Church, Kasey E Diebold, Sinmisola Ewumi, Amanda E. Faulkner, Helen Fisun, Holly Haberman, Brian H. Harcourt, Sterling Haring, Lauren Hughes, Sandeep J. Joseph, Nivritti Kumaran, Adria Lee, T. Patrick Lennon, Ruth Link‐Gelles, Lihan Lu, Jessica Marcinkevage, Leonard W. Mayer, Jenny Milucky, Christine E. Miner, Jennifer Nelson, Manisha Patel, Simon Paulos, Veronica Pinell-McNamara, Conrad P. Quinn, Gowrisankar Rajam, Romany Redman, Adam C. Retchless, Mariana Rosenthal, Vera Semenova, Tami H. Skoff, Elizabeth A. Smulian, Toscha Stanley, Erin Stratton, Pam Talley, Tejpratep Tiwari, Karrie‐Ann Toews, Matt Westercamp, Paul R. Cieslak, Malini B. DeSilva, Nick Alviani, Frances Biel, Bailey Burkhalter, Matt Francis, Phebe Howe, Esther Jackson, T. Johnson, Patrick Luedtke, Zach Manning, Ester Muno, Todd F. Roberts, Zack Roberts, Michael Eyster, Charles Hollands,

Virology and Viral Diseases

Following a serogroup B meningococcal disease outbreak at an Oregon university, a meningococcal carriage evaluation was conducted in conjunction with a MenB-FHbp and MenB-4C vaccination campaign. Neither vaccine was associated with reduced meningococcal carriage among participants.